DRKS00021182招募中不适用
Evaluation of bone mineral density and bone metabolism during treatment with the januskinaseinhibitor upadacitinib in patients with rheumatoid arthritis
Campus Kerckhoff der Jusuts-Liebig-Universität Gießen, Abteilung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin0 个研究点目标入组 60 人开始时间: 2020年3月26日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Patients > 18 years with moderate to severe active rheumatoid arthritis who are going to receive treatment with upadacitinib [Rinvoq®]. The indication for treatment with upadacitinib needs to be given by the treating rheumatologist. Only patients with RA fulfilling the ACR/EULAR classification criteria are eligible.
排除标准
- •Contraindications to treatment with upadacitinib [Rinvoq®].
- •Incompatible language barriers
- •Missing consent
- •During study: inadherence to pharmacological treatment
研究者
相似试验
已完成
不适用
Evaluation of bone mineral density and bone metabolism during treatment with januskinaseinhibitors baricitinib or tofacintib in patients with rheumatoid arthritisM05.80M06.00DRKS00020780Campus Kerckhoff der Justus Liebig Universität Giessen, Abteiliung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin89
招募中
不适用
Study of bone mineral density and renal function in cured patients of hyperparathyroidism.CTRI/2019/05/019365Department of Endocrinology
尚未招募
2 期
Effect of 1% Metformin gel on bone density.CTRI/2024/05/067922Dr Tushar Mohata
已完成
不适用
The evaluation of bone mineral density in long-term survival patients after allogeneic hematopoietic stem cell transplantation: cross sectional study by KSGCTHematological malignanciesJPRN-UMIN000030916Kanto Study Group for Cell Therapy350
尚未招募
Unknown
Comparing bone strength and implant stability in people with high cholesterol levelsCTRI/2024/07/070551Datta Meghe Institute of Higher Education and Research